SYNACT — SynAct Pharma AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK236.72m
- SEK174.97m
Annual cashflow statement for SynAct Pharma AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -24.8 | -31.3 | -76.7 | -106 | -224 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -0.126 | — | 0.088 | -0.306 | 10.2 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 8.47 | -1.95 | 11.6 | -12.6 | 38.8 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -16.1 | -33.2 | -65 | -118 | -100 |
| Capital Expenditures | -0.499 | — | — | — | — |
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | -0.093 | -0.006 | 0.027 | 0.37 |
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.499 | -0.093 | -0.006 | 0.027 | 0.37 |
| Financing Cash Flow Items | — | -5.04 | -5.6 | -27.3 | -4.75 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 13 | 44.7 | 74.3 | 201 | 54 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3.56 | 11 | 9.45 | 84.2 | -45.9 |